HIV Prevention Methods

The Latest

PrEP Use Is Correlated With an Increase in STIs, JAMA Study Finds

However, a number of leading clinicians argue that the results should not deter care providers from prescribing PrEP for patients who are most at risk for HIV.

By Sony Salzman

The Opioid Epidemic Is Fueling HIV Cluster Outbreaks -- Here's How the CDC is Responding

Epidemiologists are using a combination of molecular surveillance and tuberculosis-style contact tracing in hopes of helping local health departments curb HIV transmissions.

By Sony Salzman

This Week in HIV Research: Fentanyl Smooths the Path for HIV

April 4, 2019: what’s driving the HIV outbreak in northeastern Massachusetts; race-gender HIV disparities among Baltimore sex workers; high PrEP interest, low awareness among southern black women; naltrexone implants for opioid dependence.

By Barbara Jungwirth and Myles Helfand

Researchers Crave More Data on HIV Care Continuum Programs for Recently Incarcerated People

Sixteen years after the success of Project START for HIV risk reduction, we still don't know what works best for helping people with HIV stay in care after prison.

By Sony Salzman

Results of CDC-Funded Local Projects for MSM and Transgender People Unveiled at Prevention Conference

Project PrIDE demonstration studies in New York and Houston show that properly funded and well-designed outreach programs can impact a city's ability to provide better HIV services for underserved populations.

By Sony Salzman

Many Providers Are Biased Against Prescribing PrEP to People Who Inject Drugs

Health care providers often believe stereotypes that PWID are irresponsible and won't adhere to PrEP, according to data presented at the 2019 National HIV Prevention Conference.

By Sony Salzman

The Next Frontier of U=U Science

Undetectable equals untransmittable (U=U) has improved HIV prevention and tackled stigma, but there are still a few questions to answer.

By Sony Salzman

CDC: Most HIV Transmissions Are From People Who Are Not in Care

More than 80 percent of U.S. HIV transmissions in 2016 were from people who were unaware of their status or had been diagnosed but lost to follow-up.

By Stephen Hicks

Chemsex Doesn't Impact PrEP Adherence, New Study Finds

Although people living with HIV who "party and play" appear more likely to struggle with treatment adherence, new research suggests that concern does not apply to PrEP.

By Sony Salzman

This Week in HIV Research: Exorcizing Our PrEP Demons

Experts push for normalization of PrEP; U.S. HIV transmission rates across the care continuum; sociodemographic disadvantage and HIV drug resistance; real-world success of integrase inhibitors for treatment-experienced people.

By Myles Helfand